Ms Rachita Bhandari, Deputy Chief of Mission at the Embassy of India in Berlin, visited the Paul-Ehrlich-Institut on 20 February 2023. In November 2022, a Joint Declaration of Intent (JDI) was signed by the Central Drugs Standard Control Organisation (CDSCO), India’s national regulatory body for pharmaceuticals and medical devices; the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines; and the Federal Institute for Drugs and Medical Devices of the Federal Republic of Germany (BfArM). In the JDI, both sides agreed to strengthen cooperation in the field of pharmaceutical regulation. The signing was preceded by a decision taken at the 6th Indo-German Inter-Governmental Consultations held in Berlin in May 2022.
Both sides intend to exchange experiences in the field of pharmaceutical regulation in order to enhance their cooperation. The collaboration between the authorities will include efforts such as the exchange of information and cooperation in the field of pharmaceutical regulation, as well as the exchange of safety information with regard to medicines and medical devices. Mutual participation in scientific and practical conferences, symposia, seminars and forums organised by the authorities is also part of the JDI.
During her visit to the Paul-Ehrlich-Institut, Ms Rachita Bhandari, Deputy Chief of Mission at the Embassy of India, met with Professor Klaus Cichutek, President of the Paul-Ehrlich-Institut, to discuss and take forward collaboration between both sides. The visit also included a brief tour of the Paul-Ehrlich-Institut, including its two laboratories, as well as a briefing about the Institute’s regulatory work.
Updated: 24.02.2023
